Sage Therapeutics, Inc. (SAGE)
USD 6.45
(-5.98%)
USD 6.45
(-5.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -545.07 Million USD | 6.45% |
| 2022 | -545.86 Million USD | -18.68% |
| 2021 | -456.72 Million USD | -170.72% |
| 2020 | 626.59 Million USD | 192.03% |
| 2019 | -705.84 Million USD | -80.08% |
| 2018 | -392.09 Million USD | -43.96% |
| 2017 | -269.62 Million USD | -70.55% |
| 2016 | -160.16 Million USD | -69.22% |
| 2015 | -94.65 Million USD | -179.95% |
| 2014 | -33.81 Million USD | -85.44% |
| 2013 | -18.23 Million USD | -90.17% |
| 2012 | -9.58 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -101.2 Million USD | 8.82% |
| 2024 Q1 | -116.74 Million USD | -180.19% |
| 2024 Q2 | -110.98 Million USD | 5.41% |
| 2023 FY | - USD | 6.45% |
| 2023 Q4 | -42.09 Million USD | 70.84% |
| 2023 Q2 | -170.45 Million USD | -9.64% |
| 2023 Q3 | -144.32 Million USD | 15.33% |
| 2023 Q1 | -155.47 Million USD | -1.02% |
| 2022 Q3 | -141.2 Million USD | -10.2% |
| 2022 Q2 | -128.12 Million USD | -4.23% |
| 2022 FY | - USD | -18.68% |
| 2022 Q1 | -122.92 Million USD | 2.04% |
| 2022 Q4 | -153.9 Million USD | -8.99% |
| 2021 Q2 | -107.12 Million USD | -14.06% |
| 2021 FY | - USD | -170.72% |
| 2021 Q1 | -93.92 Million USD | -109.65% |
| 2021 Q4 | -125.48 Million USD | 3.86% |
| 2021 Q3 | -130.52 Million USD | -21.84% |
| 2020 Q4 | 973.71 Million USD | 1005.23% |
| 2020 Q2 | -81.5 Million USD | 37.76% |
| 2020 Q1 | -130.95 Million USD | 25.01% |
| 2020 FY | - USD | 192.03% |
| 2020 Q3 | -107.56 Million USD | -31.98% |
| 2019 Q1 | -169.43 Million USD | -3.17% |
| 2019 FY | - USD | -80.08% |
| 2019 Q4 | -174.63 Million USD | 6.35% |
| 2019 Q3 | -186.47 Million USD | -5.98% |
| 2019 Q2 | -175.95 Million USD | -3.85% |
| 2018 Q4 | -164.22 Million USD | -27.84% |
| 2018 FY | - USD | -43.96% |
| 2018 Q1 | -77.87 Million USD | -10.54% |
| 2018 Q2 | -21.9 Million USD | 71.88% |
| 2018 Q3 | -128.45 Million USD | -486.54% |
| 2017 Q2 | -70.72 Million USD | -23.32% |
| 2017 FY | - USD | -70.55% |
| 2017 Q4 | -70.44 Million USD | 5.28% |
| 2017 Q3 | -74.37 Million USD | -5.16% |
| 2017 Q1 | -57.35 Million USD | -1.72% |
| 2016 Q2 | -34.93 Million USD | -13.88% |
| 2016 Q1 | -30.67 Million USD | -7.2% |
| 2016 Q3 | -37.98 Million USD | -8.73% |
| 2016 FY | - USD | -69.22% |
| 2016 Q4 | -56.37 Million USD | -48.44% |
| 2015 Q1 | -16.89 Million USD | -36.87% |
| 2015 Q2 | -25.05 Million USD | -48.3% |
| 2015 Q4 | -28.61 Million USD | -18.81% |
| 2015 Q3 | -24.08 Million USD | 3.9% |
| 2015 FY | - USD | -179.95% |
| 2014 Q2 | -6.17 Million USD | -6.89% |
| 2014 Q3 | -9.47 Million USD | -53.31% |
| 2014 Q4 | -12.34 Million USD | -30.36% |
| 2014 FY | - USD | -85.44% |
| 2014 Q1 | -5.77 Million USD | -1.35% |
| 2013 FY | - USD | -90.17% |
| 2013 Q4 | -5.7 Million USD | -26.49% |
| 2013 Q1 | -3.37 Million USD | 0.0% |
| 2013 Q2 | -4.64 Million USD | -37.45% |
| 2013 Q3 | -4.5 Million USD | 2.91% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -183.657% |
| Alkermes plc | 495.04 Million USD | 210.104% |
| Agenus Inc. | -145.92 Million USD | -273.53% |
| Aptorum Group Limited | -9.59 Million USD | -5578.406% |
| Ardelyx, Inc. | -55.35 Million USD | -884.698% |
| Dyadic International, Inc. | -8.22 Million USD | -6523.175% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -187209.278% |
| Lantern Pharma Inc. | -15.78 Million USD | -3352.719% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2637.34% |
| Novavax, Inc. | -487.39 Million USD | -11.834% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -667.445% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -594.419% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2932.64% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -5368.198% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -849.998% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -43.451% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2160.585% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 103137.807% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -246.748% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -628.558% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2603.854% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2196.482% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2263.908% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -346.402% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -111.069% |
| AlloVir, Inc. | -190.14 Million USD | -186.659% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -210.277% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1762.978% |
| Bicycle Therapeutics plc | -183.4 Million USD | -197.203% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -229.505% |
| ChromaDex Corporation | -3.89 Million USD | -13897.689% |
| Chimerix, Inc. | -92.97 Million USD | -486.261% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1126.621% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -384.36% |
| CRISPR Therapeutics AG | -202.7 Million USD | -168.903% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1601.111% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -216.48% |
| Fortress Biotech, Inc. | -133.64 Million USD | -307.855% |
| Fortress Biotech, Inc. | -133.64 Million USD | -307.855% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -604.744% |
| ImmuCell Corporation | -2.5 Million USD | -21667.302% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -317.931% |
| Immix Biopharma, Inc. | -16.13 Million USD | -3278.049% |
| Incyte Corporation | 919.42 Million USD | 159.284% |
| Innoviva, Inc. | 248.96 Million USD | 318.939% |
| IO Biotech, Inc. | -91.22 Million USD | -497.481% |
| Jaguar Health, Inc. | -33.13 Million USD | -1545.196% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -258.182% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 635.816% |
| ContextLogic Inc. | -324 Million USD | -68.231% |
| MiMedx Group, Inc. | 40.51 Million USD | 1445.287% |
| MEI Pharma, Inc. | 26.38 Million USD | 2166.224% |
| NextCure, Inc. | -59.03 Million USD | -823.237% |
| Onconetix, Inc. | -36.7 Million USD | -1384.932% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 24487.919% |
| Opthea Limited | -200.01 Million USD | -172.509% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -19709.346% |
| Vaxcyte, Inc. | -464.88 Million USD | -17.248% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1259.787% |
| Precigen, Inc. | -89.22 Million USD | -510.887% |
| Pharming Group N.V. | 9.87 Million USD | 5618.579% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -242.706% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2294.649% |
| PureTech Health plc | -11.62 Million USD | -4587.968% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -3109.882% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -133.438% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2160.585% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -523.457% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1781.953% |
| Acelyrin, Inc. | -381.52 Million USD | -42.866% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -4230203.868% |
| Summit Therapeutics Inc. | 1 Million USD | 54552.547% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1532.63% |
| Senti Biosciences, Inc. | -61.33 Million USD | -788.662% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -385.352% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1214.467% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1663.752% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -8811.402% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -169703.738% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1579.567% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -6392.02% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -827.147% |
| Seer, Inc. | -97.88 Million USD | -456.847% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -776.361% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -733.887% |
| ESSA Pharma Inc. | -26.45 Million USD | -1960.343% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1293.257% |
| GT Biopharma, Inc. | 5.97 Million USD | 9216.407% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -163.71% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -7836.372% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 727.874% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -860.408% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -964.195% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -5413.05% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -0.952% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -7817.926% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -1063.139% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -130.355% |
| Aptose Biosciences Inc. | -52.26 Million USD | -942.837% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -405.897% |
| Soligenix, Inc. | -7.85 Million USD | -6841.047% |
| Century Therapeutics, Inc. | -121.2 Million USD | -349.698% |
| Kura Oncology, Inc. | -164.95 Million USD | -230.436% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -580.504% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -5304.224% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -56812.165% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -12549.571% |
| Autolus Therapeutics plc | -156.77 Million USD | -247.688% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -543.857% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -689.945% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2634.373% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -187.981% |
| GRI Bio, Inc. | -10.89 Million USD | -4901.56% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11970.514% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -344.933% |
| IGM Biosciences, Inc. | -253.35 Million USD | -115.138% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -425.156% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1329.384% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3455.367% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3362.247% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -858.871% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -408.921% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -104.916% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -181.052% |
| Verastem, Inc. | -83.16 Million USD | -555.4% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -977.81% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -244.484% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -377.759% |
| Histogen Inc. | -10.5 Million USD | -5089.66% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3717.095% |
| Surrozen, Inc. | -41.13 Million USD | -1225.205% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3581.413% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16996358.185% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -828.361% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -962.639% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2430.619% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -6437.175% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -228.225% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -1006.551% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -2155.524% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3520.515% |
| Apollomics, Inc. | -171.74 Million USD | -217.368% |
| Amarin Corporation plc | -50.9 Million USD | -970.832% |
| Mesoblast Limited | -61.33 Million USD | -788.735% |
| Turnstone Biologics Corp. | -56.23 Million USD | -869.289% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -280.633% |
| Synaptogenix, Inc. | -8.3 Million USD | -6461.174% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3453.491% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -764.545% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11275.85% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 127144.395% |
| Exelixis, Inc. | 196.6 Million USD | 377.245% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1324.573% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -285.456% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -10.068% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4520.939% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 220583.302% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1747.319% |
| Gritstone bio, Inc. | -126.86 Million USD | -329.652% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -738.763% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13526.934% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4647.583% |
| Insmed Incorporated | -654.73 Million USD | 16.75% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -24128.359% |
| MediWound Ltd. | -4.89 Million USD | -11039.792% |
| OmniAb, Inc. | -49.73 Million USD | -996.037% |
| Alector, Inc. | -142.89 Million USD | -281.456% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -538.001% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -945.237% |
| Zai Lab Limited | -366.57 Million USD | -48.693% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -87.543% |
| Aura Biosciences, Inc. | -83.69 Million USD | -551.25% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -141.986% |
| Immunic, Inc. | -99.11 Million USD | -449.954% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -313.967% |
| Veracyte, Inc. | -49.4 Million USD | -1003.18% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -7616.242% |
| FibroGen, Inc. | -261.4 Million USD | -108.516% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4792.469% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7685.237% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2812.186% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 137.606% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -2044.088% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1466.433% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2188.391% |
| Galecto, Inc. | -37.51 Million USD | -1352.784% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1324.461% |
| Fortrea Holdings Inc. | 167.3 Million USD | 425.804% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -305.92% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1825.294% |
| XBiotech Inc. | -35.76 Million USD | -1423.989% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -738.763% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -735.356% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -421.823% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2023.208% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1233.766% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -5.541% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -872.974% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -972353.658% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -368.535% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2358.642% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -131.882% |
| NexImmune, Inc. | -28.16 Million USD | -1835.102% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -9764.542% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4522.264% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 111.711% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -2046.621% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4553.488% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -333.125% |
| Ainos, Inc. | -8.77 Million USD | -6112.971% |
| Pluri Inc. | -20.22 Million USD | -2595.031% |
| Prothena Corporation plc | -190.1 Million USD | -186.716% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -325.178% |
| Celularity Inc. | -183.94 Million USD | -196.321% |
| Rallybio Corporation | -72.37 Million USD | -653.14% |
| Cue Biopharma, Inc. | -46.05 Million USD | -1083.597% |
| MeiraGTx Holdings plc | -57.05 Million USD | -855.392% |
| Omeros Corporation | -163.61 Million USD | -233.152% |
| Humacyte, Inc. | -96.45 Million USD | -465.085% |
| Immunocore Holdings plc | -59.64 Million USD | -813.796% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2713.7% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -2137.102% |
| Blueprint Medicines Corporation | -474.61 Million USD | -14.845% |
| CalciMedica, Inc. | -34.18 Million USD | -1494.285% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -644.285% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -334.329% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -223.578% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -115.963% |
| Pulmatrix, Inc. | -12.64 Million USD | -4210.217% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1553.431% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -516.128% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -7.654% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -438.527% |
| Cytokinetics, Incorporated | -456.68 Million USD | -19.354% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1533.266% |
| Nutriband Inc. | -5.12 Million USD | -10542.205% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1159.637% |
| Vor Biopharma Inc. | -114.37 Million USD | -376.581% |
| Roivant Sciences Ltd. | -996.51 Million USD | 45.302% |
| Evogene Ltd. | -23.2 Million USD | -2249.035% |
| ProKidney Corp. | -147.66 Million USD | -269.116% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -744.611% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -355808.298% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 3.607% |
| CorMedix Inc. | -48.88 Million USD | -1014.958% |
| BioLineRx Ltd. | -57.06 Million USD | -855.241% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -387.723% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -269736.634% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1401.115% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -585.476% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -570.336% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -97.845% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1673.162% |
| MediciNova, Inc. | -9.87 Million USD | -5416.92% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -332.798% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -35520.811% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1943.851% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -142.263% |
| Biomea Fusion, Inc. | -124.62 Million USD | -337.386% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -65.003% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1991.917% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -186.368% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -137.047% |
| Absci Corporation | -95.45 Million USD | -471.011% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1715.387% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -408.85% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -133.459% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2284.905% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -162.26% |
| Allakos Inc. | -189.91 Million USD | -187.007% |
| Imunon, Inc. | -19.87 Million USD | -2642.038% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -402.406% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 603.185% |
| BioAtla, Inc. | -122.24 Million USD | -345.898% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4520.939% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -3358.347% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -81.513% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1215.101% |
| XOMA Corporation | -39.36 Million USD | -1284.762% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -449.167% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -363.298% |
| aTyr Pharma, Inc. | -52.17 Million USD | -944.636% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -550.325% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -266.727% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -132.375% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3892.309% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6677.539% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3144.078% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 288946.142% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 220.605% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8431.883% |
| UroGen Pharma Ltd. | -63.83 Million USD | -753.927% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -702.577% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7404.738% |
| Orgenesis Inc. | -60.71 Million USD | -797.707% |
| Entera Bio Ltd. | -8.8 Million USD | -6091.163% |
| GH Research PLC | -41.15 Million USD | -1224.496% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -2035.938% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -562.836% |
| Xencor, Inc. | -125.87 Million USD | -333.028% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -38109.1% |
| Replimune Group, Inc. | -230.19 Million USD | -136.783% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2604.04% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4881.448% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8431.883% |
| Portage Biotech Inc. | -18.19 Million USD | -2895.055% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -35520.811% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -421.179% |
| OncoCyte Corporation | -23.12 Million USD | -2257.263% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4723.474% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4657.595% |
| Purple Biotech Ltd. | -22.22 Million USD | -2352.508% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -8403.432% |
| scPharmaceuticals Inc. | -46.06 Million USD | -1083.366% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2960.526% |
| HilleVax, Inc. | -132.46 Million USD | -311.479% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -5026.211% |
| Tharimmune, Inc. | -9.3 Million USD | -5759.337% |
| Genprex, Inc. | -31.06 Million USD | -1654.862% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -190.664% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1638.438% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -71244.241% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 361303.149% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3461569.631% |
| Savara Inc. | -59.13 Million USD | -821.77% |
| Curis, Inc. | -45.13 Million USD | -1107.537% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1675.385% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3488.076% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -7507.397% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1938.864% |
| BeiGene, Ltd. | -1.12 Billion USD | 51.533% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -3243.742% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -26.589% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -503.354% |
| Erasca, Inc. | -121.31 Million USD | -349.32% |
| bluebird bio, Inc. | -167.16 Million USD | -226.075% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -12016.016% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 275.668% |
| DBV Technologies S.A. | -85.98 Million USD | -533.935% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -12016.016% |
| Moderna, Inc. | -3.28 Billion USD | 83.397% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1179.237% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -9550.673% |
| Molecular Templates, Inc. | 1.43 Million USD | 38216.783% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -810.696% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -67.073% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -297.603% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -1050.762% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -292.041% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -164.777% |
| MacroGenics, Inc. | 2.01 Million USD | 27123.798% |
| RenovoRx, Inc. | -11.39 Million USD | -4685.514% |
| Adicet Bio, Inc. | -136.53 Million USD | -299.216% |
| Prime Medicine, Inc. | -193.75 Million USD | -181.313% |
| Aditxt, Inc. | -25.45 Million USD | -2041.059% |
| Adagene Inc. | -14.95 Million USD | -3545.762% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7356.398% |
| Quantum-Si incorporated | -91.8 Million USD | -493.732% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 176.511% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 531.039% |
| SciSparc Ltd. | -5.28 Million USD | -10219.387% |
| Vericel Corporation | 2.86 Million USD | 19131.774% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -572404.411% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2412.836% |
| Generation Bio Co. | -133.3 Million USD | -308.905% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -556.474% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -533.633% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -139.661% |
| Invivyd, Inc. | -196.61 Million USD | -177.227% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -45.681% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5776.893% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 2107.329% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5199.66% |
| 2seventy bio, Inc. | -206.41 Million USD | -164.061% |
| ADMA Biologics, Inc. | 5.12 Million USD | 10745.898% |
| Clene Inc. | -43.24 Million USD | -1160.54% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2268.945% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -1024.389% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1943.851% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -81.953% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1384.018% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2412.264% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 11200.645% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1578.068% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -244.101% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 20.347% |
| Evaxion Biotech A/S | -21.4 Million USD | -2446.699% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -720.703% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -150.412% |
| Trevena, Inc. | -35.28 Million USD | -1444.633% |
| Surrozen, Inc. | -41.13 Million USD | -1225.205% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -584.83% |
| Cingulate Inc. | -22.95 Million USD | -2274.823% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -7205.589% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1361.98% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -6525.886% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -432.992% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -703.618% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -833.787% |
| Clearmind Medicine Inc. | -8.71 Million USD | -6157.503% |
| Kronos Bio, Inc. | -121.83 Million USD | -347.402% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -633.193% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -22225.996% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -440.599% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1499.95% |
| ImmunityBio, Inc. | -436.18 Million USD | -24.964% |
| Korro Bio, Inc. | -80.9 Million USD | -573.724% |
| Kineta, Inc. | -15.71 Million USD | -3368.69% |
| BioVie Inc. | -31.95 Million USD | -1605.998% |
| Codexis, Inc. | -49.28 Million USD | -1006.0% |
| Celularity Inc. | -183.94 Million USD | -196.321% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -146.07% |
| Celcuity Inc. | -58.3 Million USD | -834.78% |
| Virax Biolabs Group Limited | -6.6 Million USD | -8147.21% |
| Cibus, Inc. | -314.58 Million USD | -73.266% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1515.836% |
| IN8bio, Inc. | -28.5 Million USD | -1812.258% |
| Kodiak Sciences Inc. | -259.02 Million USD | -110.433% |
| Annexon, Inc. | -141.57 Million USD | -285.004% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -384.081% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -749.072% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1849.812% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -136.977% |
| Eyenovia, Inc. | -24.1 Million USD | -2161.135% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1317.109% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -168131.481% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -638.537% |
| Arcellx, Inc. | -64.14 Million USD | -749.747% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1110.89% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -341.438% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1665.009% |
| Moolec Science SA | -52.07 Million USD | -946.691% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -956.214% |
| Geron Corporation | -174.78 Million USD | -211.857% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1248.616% |
| Royalty Pharma plc | 1.88 Billion USD | 128.881% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -355.771% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5745.722% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2528.014% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -228.197% |
| Humacyte, Inc. | -96.45 Million USD | -465.085% |
| Structure Therapeutics Inc. | -102.45 Million USD | -431.988% |
| 89bio, Inc. | -134.46 Million USD | -305.368% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -591.055% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 13551.876% |
| Genelux Corporation | -24.16 Million USD | -2155.618% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1512.633% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -233.45% |
| Notable Labs, Ltd. | -14.4 Million USD | -3685.208% |
| Liquidia Corporation | -70.05 Million USD | -678.105% |
| Mustang Bio, Inc. | -48.06 Million USD | -1034.074% |
| Immunovant, Inc. | -269.97 Million USD | -101.894% |
| Quantum-Si incorporated | -91.8 Million USD | -493.732% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -667.856% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2723.027% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -434.319% |
| Acasti Pharma Inc. | -11.3 Million USD | -4723.201% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2349.396% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3455.367% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -158.925% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -12664.08% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3332.431% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1794.183% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1371.969% |
| PepGen Inc. | -83.58 Million USD | -552.138% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1747.444% |
| United Therapeutics Corporation | 1.38 Billion USD | 139.304% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2280.53% |
| Solid Biosciences Inc. | -93.43 Million USD | -483.374% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -11322.887% |
| Immuneering Corporation | -58.06 Million USD | -838.792% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 16996358.185% |
| Silo Pharma, Inc. | -3.62 Million USD | -14931.38% |
| Belite Bio, Inc | -31.52 Million USD | -1628.789% |
| XOMA Corporation | -39.36 Million USD | -1284.762% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -708.146% |
| Bionomics Limited | -9.83 Million USD | -5441.021% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -549.009% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1475.074% |
| uniQure N.V. | -253.1 Million USD | -115.358% |
| Cassava Sciences, Inc. | -95.68 Million USD | -469.639% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7356.398% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -320.89% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1578.326% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6670.658% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1831.571% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -168131.481% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4792.469% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3327.898% |
| Altimmune, Inc. | -87.93 Million USD | -519.856% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -491.959% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1475.074% |
| Compugen Ltd. | -12.51 Million USD | -4254.986% |
| Peak Bio, Inc. | -1356.23 USD | -40189985.752% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -1021.589% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2323.61% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -124.954% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1809.645% |
| Zura Bio Limited | -60.56 Million USD | -800.005% |
| PolyPid Ltd. | -20.26 Million USD | -2589.977% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3391.129% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1809.645% |
| Instil Bio, Inc. | -146.12 Million USD | -273.024% |
| argenx SE | -216.02 Million USD | -152.32% |
| Immunome, Inc. | -28.27 Million USD | -1828.018% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -1024.482% |
| Verona Pharma plc | -52.46 Million USD | -938.87% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -475.138% |
| Shattuck Labs, Inc. | -87.61 Million USD | -522.12% |
| CervoMed Inc. | -2.17 Million USD | -24996.76% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -345.887% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -4194.257% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1031.461% |
| Moolec Science SA | -52.07 Million USD | -946.691% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -3080.108% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -318.027% |
| AnaptysBio, Inc. | -143.16 Million USD | -280.731% |
| Design Therapeutics, Inc. | -66.32 Million USD | -721.817% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -573.034% |
| NeurAxis, Inc. | -6.66 Million USD | -8078.714% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1343.894% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1390.484% |
| Achilles Therapeutics plc | -70.44 Million USD | -673.786% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -475.138% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2362.588% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 9450.607% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -22225.996% |
| Nutriband Inc. | -5.12 Million USD | -10542.205% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -396.656% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -883.313% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -978.279% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -735.011% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -907.338% |
| Palisade Bio, Inc. | -12.28 Million USD | -4338.319% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1101.23% |
| Beam Therapeutics Inc. | -156.47 Million USD | -248.348% |
| Neurogene Inc. | -52.28 Million USD | -942.478% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -299.348% |
| AEON Biopharma, Inc. | -48.36 Million USD | -1027.086% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -485.983% |
| Sesen Bio, Inc. | -50.84 Million USD | -972.128% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -565.271% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -4313.514% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -27.522% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -418.142% |
| Athira Pharma, Inc. | -116.7 Million USD | -367.057% |
| Vaccinex, Inc. | -19.74 Million USD | -2660.128% |
| HCW Biologics Inc. | -23.57 Million USD | -2211.964% |
| XOMA Corporation | -39.36 Million USD | -1284.762% |
| Nektar Therapeutics | -243.1 Million USD | -124.21% |
| Arvinas, Inc. | -394.8 Million USD | -38.062% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 288946.142% |
| Merus N.V. | -149.2 Million USD | -265.311% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -483.025% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1643.666% |
| Rezolute, Inc. | -68.42 Million USD | -696.618% |
| Clene Inc. | -43.24 Million USD | -1160.54% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3434.323% |
| BeyondSpring Inc. | -21.54 Million USD | -2430.501% |
| Synlogic, Inc. | -55.16 Million USD | -888.144% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -4411.049% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -5021.876% |
| Peak Bio, Inc. | -1356.23 USD | -40189985.752% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1578.947% |
| Krystal Biotech, Inc. | 17.9 Million USD | 3144.403% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -360.274% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -59.683% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -11732.802% |
| MannKind Corporation | 15.12 Million USD | 3702.816% |
| Ikena Oncology, Inc. | -74.39 Million USD | -632.651% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -4228.357% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2781.507% |
| Gossamer Bio, Inc. | -172.15 Million USD | -216.621% |
| CohBar, Inc. | -12.06 Million USD | -4417.495% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -2036.775% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1715.387% |
| Legend Biotech Corporation | -477.87 Million USD | -14.062% |
| Mural Oncology plc | -192.72 Million USD | -182.83% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -377.905% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3276.035% |
| Disc Medicine, Inc. | -91.02 Million USD | -498.814% |
| Champions Oncology, Inc. | -5.05 Million USD | -10684.923% |
| REGENXBIO Inc. | -239.46 Million USD | -127.621% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4985.468% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -877.599% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1305.969% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -383.192% |
| Vaxart, Inc. | -74.72 Million USD | -629.454% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1448.129% |
| Cellectis S.A. | -98.09 Million USD | -455.655% |
| Longeveron Inc. | -20.06 Million USD | -2617.198% |
| Repare Therapeutics Inc. | -114.27 Million USD | -376.989% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -24.106% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -628.586% |
| Revolution Medicines, Inc. | -430.58 Million USD | -26.589% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -8567.038% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1670.34% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -630.755% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 11217.071% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4870.999% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 111.836% |
| Denali Therapeutics Inc. | -179.97 Million USD | -202.862% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -572404.411% |
| Veru Inc. | -89.97 Million USD | -505.798% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1927.941% |
| Cingulate Inc. | -22.95 Million USD | -2274.823% |
| Passage Bio, Inc. | -98.34 Million USD | -454.265% |
| Context Therapeutics Inc. | -25.06 Million USD | -2075.01% |
| Exicure, Inc. | -15.53 Million USD | -3407.755% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -164.515% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1374.118% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -9041.488% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -223.553% |
| Nuvalent, Inc. | -149.49 Million USD | -264.615% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -6602.437% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -534.584% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1706.183% |
| OmniAb, Inc. | -49.73 Million USD | -996.037% |
| Anew Medical, Inc. | -1.3 Million USD | -41801.387% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -4308.525% |
| Lipocine Inc. | -16.32 Million USD | -3239.344% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -717.564% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -633.577% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1329.384% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1297.114% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2357.152% |
| Ocugen, Inc. | -64.82 Million USD | -740.807% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -488.819% |
| Q32 Bio Inc. | -86.5 Million USD | -530.124% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -3120.122% |
| Alumis Inc. Common Stock | -156.89 Million USD | -247.422% |
| Equillium, Inc. | -12.13 Million USD | -4390.608% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -832.19% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6796.697% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2789.936% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -1067.373% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -412.549% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2947.367% |
| Dominari Holdings Inc. | -22.44 Million USD | -2329.011% |
| Edesa Biotech, Inc. | -8.19 Million USD | -6555.196% |
| vTv Therapeutics Inc. | -25.41 Million USD | -2044.932% |
| Bio-Techne Corporation | 326.66 Million USD | 266.86% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -41.627% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 351.894% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -315.741% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1356.199% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -260.732% |
| Nkarta, Inc. | -120.48 Million USD | -352.412% |
| BioCardia, Inc. | -11.56 Million USD | -4615.138% |
| Iterum Therapeutics plc | -34.58 Million USD | -1476.258% |